Sexually Transmitted Infections: A Case Challenge
Sexually transmitted infection cases have reached an all-time high at an alarming speed. Test your knowledge of different treatment options with our new case challenge.   (Source: ConsultantLive)
Source: ConsultantLive - April 17, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Sexually Transmitted Diseases Source Type: news

Neuropsychiatric Symptoms in Hepatitis C Patients Neuropsychiatric Symptoms in Hepatitis C Patients
How do neuropsychiatric symptoms differ among those with hepatitis C versus other manifestations of hepatitis, and what insights might these differences provide regarding their etiology?Journal of Viral Hepatitis (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - April 17, 2019 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

Betty J. Dong Receives Daniel B. Smith Practice Excellence Award for exceptional career
Dong is a world expert on human immunodeficiency virus (HIV) and hepatitis C medication therapy (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - April 15, 2019 Category: Universities & Medical Training Source Type: news

Need to Inject Then Infect a Human to Test Hep C Vaccine Need to Inject Then Infect a Human to Test Hep C Vaccine
Hepatitis C will not be eradicated without a vaccine, and an effective vaccine needs a challenge test in healthy humans, experts say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 15, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

New class of medicines shows promise
'Gene silencing' spares patients the crippling pain of intermittent porphyria Related items fromOnMedica Higher cancer risk from chronic diseases Hepatocellular carcinoma risk, cirrhosis and hepatitis C Kidney disease hits 850 million people Commonest genetic mutation causes much morbidity Prevention screening for one third of population (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 15, 2019 Category: UK Health Source Type: news

Glecaprevir/pibrentasvir is effective and well tolerated in individuals with hepatitis C
(Spink Health) Two large 'real-world' studies conducted in Germany and the USA have confirmed the high rates of sustained virological response (SVR) observed in controlled clinical studies of glecaprevir/pibrentasvir (G/P) involving individuals with hepatitis C virus (HCV) infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 11, 2019 Category: Infectious Diseases Source Type: news

Hepatitis C in England 2019
This report summarises the current data, the impact of action plans in England to drive down mortality from hepatitis C virus infection and to reduce the number of new infections, and outline the actions required to make further progress. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 10, 2019 Category: Consumer Health News Source Type: news

Hepatitis C could be prevented worldwide by reducing transmission in people who inject drugs
Stepping up efforts to prevent transmission of hepatitis C among people who inject drugs, could reduce future infections by 43 per cent globally, according to a study by researchers at the University of Bristol published in the Lancet Gastroenterology and Hepatology today [Tuesday 9 April 2019]. (Source: University of Bristol news)
Source: University of Bristol news - April 10, 2019 Category: Universities & Medical Training Tags: International, Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

High Response Seen for All Hep C Tx Models in Injection Drug Users
TUESDAY, April 9, 2019 -- For people with hepatitis C virus (HCV) who inject drugs (PWID) and receive opioid agonist therapy (OAT), receipt of HCV treatment is associated with high sustained virologic response (SVR), according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2019 Category: Pharmaceuticals Source Type: news

Hepatitis C deaths fall 16% in two years
Deaths from serious hepatitis C related liver disease fell from 380 to 319 between 2015 and 2017, thanks to new curative treatments. (Source: NHS Networks)
Source: NHS Networks - April 9, 2019 Category: UK Health Source Type: news

Significant fall in Hepatitis C deaths
And new treatments mean fewer people now require liver transplants Related items fromOnMedica Range of new and costly drugs added to WHO ‘essentials’ list UK joins fight against Ebola GPs should administer Hep C therapy, says WHO UK falls behind other nations in preventing avoidable death Common anti-parasitic could be new tool for malaria control (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 9, 2019 Category: UK Health Source Type: news

Hep C-Infected Lungs, Hearts OK for Transplant
The new transplant policy calls for recipients to receive hepatitis C antivirals starting a few hours after leaving the operating room. This strategy could increase the number of potential organs available to patients by 20% to 25%, the lead researcher said. (Source: WebMD Health)
Source: WebMD Health - April 4, 2019 Category: Consumer Health News Source Type: news

Lungs, Hearts Infected With Hepatitis C Still OK for Transplant
Title: Lungs, Hearts Infected With Hepatitis C Still OK for TransplantCategory: Health NewsCreated: 4/3/2019 12:00:00 AMLast Editorial Review: 4/4/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - April 4, 2019 Category: Nutrition Source Type: news

Successful transplants may change the rules
Doctors have been able to safely transplant organs from donors infected with hepatitis C (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 4, 2019 Category: Consumer Health News Source Type: news

Hygiene and Health: Are We Too Clean?
How do we combat waning human immunity? Our slide show summarizes 5 new reports that suggest it ’s essential to figure that out. (Source: ConsultantLive)
Source: ConsultantLive - April 4, 2019 Category: Internal Medicine Authors: Leo Robert Tags: Allergy Hepatitis C Source Type: news

Transplants with infected organs can be safe, study finds
Due to the opioid crisis, more donated organs are infected with the hepatitis C virus and many are declined as a result. Now researchers at Brigham and Women ’s Hospital in Boston are using a new approach to protect transplant patients and enable the use of infected donor organs. Dr. Mallika Marshall reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 4, 2019 Category: Consumer Health News Source Type: news

More heart, lung transplants possible with therapy to clear Hep C from donor organs
(Reuters Health) - The presence of hepatitis C in potential organ donors has long prevented hearts and lungs from going to patients who desperately need them, but that prohibition may soon disappear thanks to a technique that attacks the virus before it can gain a foothold in the recipient. (Source: Reuters: Health)
Source: Reuters: Health - April 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Study: Safe to transplant hepatitis C-infected hearts, lungs
A new study suggests doctors can safely transplant lungs or hearts from hepatitis C-positive donors without infecting the recipients (Source: ABC News: Health)
Source: ABC News: Health - April 3, 2019 Category: Consumer Health News Tags: Health Source Type: news

Heart, Lungs From Hep C-Infected Donor Can Be Transplanted Safely
WEDNESDAY, April 3, 2019 -- Hearts and lungs from donors with hepatitis C viremia can be safely transplanted into patients without hepatitis C virus (HCV) infection, according to a study published online April 3 in the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 3, 2019 Category: Pharmaceuticals Source Type: news

Lungs, Hearts Infected With Hepatitis C Still OK for Transplant
WEDNESDAY, April 3, 2019 -- Patients in dire need of an organ transplant can safely receive a new heart or lung from donors who have hepatitis C, a new clinical trial has shown. By swiftly administering powerful antiviral drugs, doctors can prevent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 3, 2019 Category: General Medicine Source Type: news

Hepatitis C-Infected Hearts and Lungs Safely Transplanted
Team prevents transmission of virus, reports good outcomes at 6 months for 35-of-35 thoracic organ recipients (Source: BWH News)
Source: BWH News - April 3, 2019 Category: Hospital Management Source Type: news

Hepatitis C-infected hearts and lungs safely transplanted
(Brigham and Women's Hospital) In a paper published in the New England Journal of Medicine, the team describes a four-week antiviral treatment regimen started within hours of organ transplantation surgery, preventing establishment of hepatitis C virus (HCV) infection in all patients, and, in so doing, expanding the pool of eligible heart and lung donor organs. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 3, 2019 Category: Infectious Diseases Source Type: news

ask Can hepatitis C be cured on its own
Can Hepatitis C Be Cured on Its Own? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 2, 2019 Category: General Medicine Source Type: news

ask Can You Get Hepatitis C from Drinking
Can You Get Hepatitis C from Drinking? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 2, 2019 Category: General Medicine Source Type: news

ask Can You Die from Hepatitis C
Can You Die from Hepatitis C? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 2, 2019 Category: General Medicine Source Type: news

Slight decline in hepatitis C diagnoses in Europe
(European Centre for Disease Prevention and Control (ECDC)) European surveillance data show a 10% decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31,000 recorded cases in 2017, diagnoses remain at a high level in the European Union and European Economic Area (EU/EEA). In addition, variation in national testing practices and widespread under-reporting of diagnosed cases do not provide an accurate picture of the true epidemiological burden. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 2, 2019 Category: Infectious Diseases Source Type: news

Medical Sequelae Impact QoL Among Individuals in Recovery
More than one-third of those in recovery from drug/alcohol use have chronic physical disease. A new study looks at prevalence of health issues by type of substance used. (Source: ConsultantLive)
Source: ConsultantLive - April 1, 2019 Category: Internal Medicine Authors: Patient Care Editorial Staff Tags: COPD Diabetes Hepatitis C Source Type: news

What Does the Liver Do?
Discussion The liver is one of the largest organs in the body, weighing just over 3 pounds in an adult. It is found in the upper right abdomen, under the right dome of the diaphragm. Grossly, it has asymmetric lobes with the right being larger than the left. The lobes are separated by a fibrous connective tissue band that also anchors the liver in the abdominal cavity. The gallbladder is located on the inferior surface of the liver and stores bile, which is then released into the duodenum. Microscopically, the liver cells are arranged in lobules with canals carrying blood vessels and bile ducts. At any moment about 10-13% ...
Source: PediatricEducation.org - April 1, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Three Philadelphia dental offices closed after exposing 1,500 patients to HIV and hepatitis
All three Trieu Family Dental locations in Philadelphia were closed after staff exposed as many as 1,500 patients to hepatitis B, hepatitis C and HIV because of poor hygiene practices. (Source: the Mail online | Health)
Source: the Mail online | Health - March 26, 2019 Category: Consumer Health News Source Type: news

HBV, HCV Control Aids Kidney Transplant Outcomes
MONDAY, March 25, 2019 -- The outcomes of kidney transplants in patients with viral suppression are as good as those for kidney transplants in patients not infected with hepatitis B virus (HBV) or hepatitis C virus (HCV), according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 25, 2019 Category: Pharmaceuticals Source Type: news

Researchers find method to prioritize treatment strategies in hepatitis C in US prisons
(Institute for Operations Research and the Management Sciences) There are currently more than three million people in the US with hepatitis C, a condition that can lead to serious and even deadly liver complications. In the US prison system, the prevalence of hepatitis C virus (HCV) infection is currently 10 times higher than the national average. However, new research in the INFORMS journal Operations Research, has identified new protocols that could substantially decrease HCV infection in the US prison system. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 22, 2019 Category: Infectious Diseases Source Type: news

5 HCV Cases: How Would You Proceed?
Sample:  A 36-year-old former IV drug user tests positive for chronic HCV and wants to know the likelihood of cure if she completes treatment. How should you counsel her? (Source: ConsultantLive)
Source: ConsultantLive - March 18, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Hepatitis C Quiz Source Type: news

HCV Infection is Associated With Insulin Resistance HCV Infection is Associated With Insulin Resistance
A new study examines the tissue-specific contribution to insulin sensitivity in hepatitis C. Does insulin sensitivity improve with viral eradication?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 18, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Hepatitis C: Is Eradication Possible? Hepatitis C: Is Eradication Possible?
Despite the availability of highly effective direct-acting antiviral therapeutic regimens, many barriers to HCV eradication persist.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 18, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Antiviral therapy improves survival rates for kidney transplant recipients with hepatitis B or C
(Elsevier) Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B (HBV) or hepatitis C (HCV) experienced poor outcomes. In a new study in the Journal of Hepatology, published by Elsevier, researchers report favorable 10-year survival rates for patients with HBV and/or HCV treated with antiviral agents and advise that antiviral therapy should be systematically offered to all HBV and HCV patients in line with international recommendations. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 14, 2019 Category: Infectious Diseases Source Type: news

Anti-viral treatment may lower diabetes risk
Research, presented at the Annual Conference on Retroviruses and Opportunistic Infections, suggests that antiviral treatment for hepatitis C may reduce the risk of diabetes.Medpage Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 11, 2019 Category: Endocrinology Source Type: news

Direct-Acting Antivirals Tied to Lower Risk of Liver Cancer in HCV
A new study found that direct-acting antiviral treatment is linked to decreased risk of liver cancer, liver-related death, and all-cause mortality.   (Source: ConsultantLive)
Source: ConsultantLive - March 7, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Source Type: news

Direct-Acting Antivirals Not Linked to Liver Cancer Recurrence
Results of the largest study of its kind may help quell longstanding controversy surrounding the impact of DAA therapy on recurrence of HCC. (Source: ConsultantLive)
Source: ConsultantLive - March 7, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Source Type: news

Computer-designed vaccine elicits potent antibodies against RSV
(University of Washington Health Sciences/UW Medicine) A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus, a major cause of infant mortality worldwide, has been developed through computer design. Animal tests suggest the vaccine could provide potent, durable protection against RSV. The vaccine is being further developed for possible clinical trials. The nanoparticle platform will also be used to design potential vaccines for AIDS, hepatitis C and cancer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 7, 2019 Category: Infectious Diseases Source Type: news

Liver Transplant Listing for HCV-associated Cirrhosis and HCC Liver Transplant Listing for HCV-associated Cirrhosis and HCC
How has the availability of direct-acting antiviral therapy impacted liver transplantation indications and waiting list outcomes in patients with chronic hepatitis C?Journal of Viral Hepatitis (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 6, 2019 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

Companies, states interested in Louisiana hepatitis C plan
Three drug companies are interested in Louisiana's plan to use a Netflix-style subscription model to buy access to hepatitis C drugs for Medicaid patients and prisoners (Source: ABC News: Health)
Source: ABC News: Health - March 1, 2019 Category: Consumer Health News Tags: Health Source Type: news

What Is the Most Common Type of Cardiomyopathy?
Discussion Barth syndrome is characterized by a dilated cardiomyopathy, proximal skeletal muscle weakness, neutropenia and short stature that usually presents at birth or soon after. It is a rare X-linked recessive disease process caused by mutations in the TAZ gene. The TAZ gene codes for tafazzin which alters cardiolipin in mitochondria. Characteristic facies can be seen especially in infancy including a tall and broad forehead, prominent chin and full cheeks, larger ears, and deep-set eyes. Most patients present at birth or soon afterwards but some may not until later in life. Life expectancy is reduced with many childr...
Source: PediatricEducation.org - February 25, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

CDC Guidance on HCV Screening: 5 Questions
CDC guidance on hepatitis C screening is mandatory primary care reading. Test your recall with these 5 questions on CDC recommendations. (Source: ConsultantLive)
Source: ConsultantLive - February 21, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Source Type: news

Improving Hepatitis C DAA Access and Uptake Improving Hepatitis C DAA Access and Uptake
How does treatment with DAAs alter the social and individual experience of living with hepatitis C? This commentary highlights the need for an individual focus for outcome measures.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 20, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Countries Use Novel Strategies to Tackle Price of HCV Drugs Countries Use Novel Strategies to Tackle Price of HCV Drugs
Both Australia and Brazil have rolled out innovative strategies to lower the cost of high-priced direct-acting antivirals, with the goal of treating all patients with hepatitis C.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 14, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

HCV Eradication Tied to Lower Risks of Premature Death and Liver Cancer (CME/CE)
(MedPage Today) -- " Best evidence to date " backs direct-acting antivirals in all hepatitis C patients (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - February 13, 2019 Category: Gastroenterology Source Type: news

Newer HCV Drugs Reduce Mortality, Liver Cancer Risk Newer HCV Drugs Reduce Mortality, Liver Cancer Risk
Treatment with direct-acting antivirals appears to reduce the risk of death and liver cancer among patients with chronic hepatitis C virus (HCV), including those with cirrhosis, new data has shown.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 13, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Study Reaffirms Safety of Hepatitis C Meds in Liver Cancer Patients
Title: Study Reaffirms Safety of Hepatitis C Meds in Liver Cancer PatientsCategory: Health NewsCreated: 2/12/2019 12:00:00 AMLast Editorial Review: 2/13/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - February 13, 2019 Category: Nutrition Source Type: news

Hep C Can Be Eliminated by 2030, Worldwide
A new study models the impact of 4 key public health interventions on global HCV burden to see if WHO elimination targets are realistic. (Source: ConsultantLive)
Source: ConsultantLive - February 12, 2019 Category: Internal Medicine Authors: Mark L. Fuerst Tags: Hepatitis C Source Type: news